Alexion pharmaceuticals share price

Alexion Pharmaceuticals has a market capitalization of $19.94 billion and generates $4.99 billion in revenue each year. The biopharmaceutical company earns $2.40 billion in net income (profit) each year or $9.74 on an earnings per share basis. Alexion Pharmaceuticals employs 3,082 workers across the globe.

ALXN Stock Price, Forecast & News (Alexion Pharmaceuticals) Alexion Pharmaceuticals has a market capitalization of $19.94 billion and generates $4.99 billion in revenue each year. The biopharmaceutical company earns $2.40 billion in net income (profit) each year or $9.74 on an earnings per share basis. Alexion Pharmaceuticals employs 3,082 workers across the globe. Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Analyst ... Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Analyst Research. ALXN Analyst Ratings. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Historical Lookup | Alexion Pharmaceuticals, Inc.

Mar 17, 2020 · To wit, the Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) share price managed to fall 57% over five long years. That’s not a lot of fun for true believers. We also note that the stock has performed poorly over the last year, with the share price down 40%. The falls have accelerated recently, with the share price down 27% in the last three months.

Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Alexion Pharmaceuticals as of April 01, 2020 is 89.93.. The all-time high Alexion Pharmaceuticals stock closing price was 207.84 on July 23, 2015.; The Alexion Pharmaceuticals 52-week high stock price is 141.86, which is 57.7% above the current share price. ALXN Price Target and Analyst Ratings (Alexion ... Nov 09, 2019 · 21 Wall Street analysts have issued ratings and price targets for Alexion Pharmaceuticals in the last 12 months. Their average twelve-month price target is $148.20, suggesting that the stock has a possible upside of 65.09%. The high price target for ALXN is $180.00 and the low price … ALXN - Alexion Pharmaceuticals Inc Share Price Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). Alexion Pharmaceuticals Inc, ALXN:NSQ summary - FT.com

5 Sep 2017 The rating on Alexion Pharma's shares was improved to a Buy from Neutral and the price target on the shares was increased from $163 to $175 

Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees Feb 27 2020; Alexion Pharmaceuticals Inc (ALXN:NSQ) closed at 89.79, 23.56% above the 52 week low of 72.67 set on Mar 16, Share price information may be rounded up/down and therefore not entirely accurate. Investment Calculator | Alexion Pharmaceuticals, Inc. The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. Alexion Pharmaceuticals Inc Share Price USD0.0001

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have 

ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. 17 Mar 2020 If You Had Bought Alexion Pharmaceuticals (NASDAQ:ALXN) Stock Five Years Ago, You'd Be Sitting On A 57% Loss, Today. Simply Wall St  Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Alexion Pharmaceuticals  Alexion Pharmaceuticals Inc. ALXN:NASDAQ. Real Time Quote | Last NASDAQ LS, VOL From CTA | USD. Extended Hours. Last Yield | 04/02/2020. 89.6315 %. Exploring Alexion Pharmaceuticals (NASDAQ:ALXN) stock? View ALXN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC  Alexion Pharmaceuticals (NASDAQ:ALXN) Share Price and News. Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the   Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company 

ALXN: Dividend Date & History for Alexion Pharmaceuticals ...

ALEXION PHARMACEUTICALS analysts consensus, targets, ratings and recommendations | Nasdaq: ALXN | Nasdaq

Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. ALXN | Complete Alexion Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. 17 Mar 2020 If You Had Bought Alexion Pharmaceuticals (NASDAQ:ALXN) Stock Five Years Ago, You'd Be Sitting On A 57% Loss, Today. Simply Wall St  Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Alexion Pharmaceuticals